The Chemours Company (CC) Cash Flow Statement

The gap between net income and operating cash flow is the central signal in this dataset, since OCF remained positive in seven of the ten quarters even when net losses reached $274.0M in Q2 2026 and $381.0M in Q2 2025. This pattern suggests that large portions of the reported losses may be non-cash or timing-related, such as impairments, accruals, or working capital reversals, though the provided data does not itemize these components. Investors should monitor whether cash conversion holds once non-recurring items are identified, rather than treating positive OCF as proof of underlying earnings strength.

Free cash flow appears dominated by working capital swings, as evidenced by the -$729.0M working capital outflow in Q2 2024 and the $298.0M inflow in Q2 2025, which together explain much of the FCF variance. Excluding these swings, underlying quarterly FCF appears more modest, with recent quarters ranging from roughly $21.0M to $98.0M. The Q3 2026 FCF of $98.0M and 6.4% margin may indicate improvement, but a single quarter is insufficient to establish a durable trend without evidence that working capital normalization continues.

Several quarters show CapEx below the reported D&A run rate, which may indicate that the asset base is being underinvested relative to depreciation, a pattern that can flatter near-term free cash flow. Quarterly capex intensity fell from 7.8% of revenue in Q4 2024 to 2.7% in Q3 2025 and 3.3% in Q3 2026, which could reflect discretionary deferral rather than a structural shift in capital needs. Analysts should assess whether this reduced spending is sustainable given the regulatory and capacity requirements of the chloride-route and fluoropolymer operations.

The magnitude of working capital swings relative to operating income suggests that inventory build-ups and collection timing play an outsized role in reported cash generation. The reversal pattern between Q2 2024 and Q2 2025 may indicate seasonal or inventory-cycle effects tied to TiO2 demand, though the provided data does not disclose inventory or receivables breakdowns. Investors should monitor whether working capital releases are sustainable or represent one-time liquidations that flatter current period cash.

The consistent dividend outflow of modest size, combined with zero reported buybacks and acquisitions, may suggest management is prioritizing balance sheet flexibility given the volatile earnings and cash profile. The dividend burden appears small relative to peak quarterly OCF, but its coverage weakens in quarters where FCF is negative, such as Q1 2026 and Q1 2025. Investors should monitor whether dividend coverage by free cash flow is maintained across the full cycle.

Summing the reported quarters, cumulative net income is deeply negative while cumulative OCF is positive, which suggests that the historical loss record may overstate the cash burn of the business. However, this divergence also means that reported earnings may not reflect the full economic cost of ongoing PFAS-related and legacy obligations, which may not appear in operating cash flow until settled. Analysts should treat the favorable cumulative cash picture with caution until the composition of non-cash charges is clarified.